(Q37357542)

19 August 2017

1 reference

title

Current research on PONV/PDNV: Practical implications for today's pharmacist (English)

1 reference

19 August 2017

Robert J Ignoffo

1

1 reference

19 August 2017

publication date

1 January 2009

1 reference

American Journal of Health-System Pharmacy

19 August 2017

published in

1 reference

19 August 2017

volume

66

1 reference

19 August 2017

issue

1 Suppl 1

1 reference

19 August 2017

page(s)

S19-24

1 reference

Practice guidelines for postanesthetic care: a report by the American Society of Anesthesiologists Task Force on Postanesthetic Care.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

ASPAN'S evidence-based clinical practice guideline for the prevention and/or management of PONV/PDNV.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

A factorial trial of six interventions for the prevention of postoperative nausea and vomiting

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

The impact of current antiemetic practices on patient outcomes: a prospective study on high-risk patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

Combination antiemetics: what is the evidence?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

Pharmacological prophylaxis and management of adult postoperative/postdischarge nausea and vomiting

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080457

31 March 2020

Identifiers

DOI

10.2146/AJHP080457

1 reference

19 August 2017

1 reference